EMCITATE
RARE THYROID · TIRATRICOL
Open FDA's page for this record- Application number
- NDA220963
- Sponsor name
- RARE THYROID
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260928
- Review priority
- PRIORITY
- Submission class code
- TYPE 1
- Submission class code description
- Type 1 - New Molecular Entity
- Submission property type
- Code
- Orphan
- Application docs
- ID
- 87316
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/220963Orig1s000ltr.pdf
- Date
- 20260929
- Type
- Letter
- ID
- 87326
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220963Orig1s000lbl.pdf
- Date
- 20260929
- Type
- Label
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- EMCITATE
- Reference standard
- Yes
- Dosage form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Active ingredients
- Name
- TIRATRICOL
- Strength
- 350MCG
